| P50 | author | Camilla Bellone | Q27925399 |
| P2093 | author name string | Fabrizio Gardoni | |
| P2860 | cites work | Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity | Q63256021 |
| | D1 dopamine receptor-induced cyclic AMP-dependent protein kinase phosphorylation and potentiation of striatal glutamate receptors | Q73229632 |
| | Striatal medium-sized spiny neurons: identification by nuclear staining and study of neuronal subpopulations in BAC transgenic mice | Q21143854 |
| | Missing pieces in the Parkinson's disease puzzle | Q22251063 |
| | Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease | Q24657764 |
| | The physiology, signaling, and pharmacology of dopamine receptors | Q28305030 |
| | Increased Cerebrospinal Fluid Dopamine and 3,4‐Dihydroxyphenylacetic Acid Levels in Huntington's Disease: Evidence for an Overactive Dopaminergic Brain Transmission | Q28343012 |
| | Drug-driven AMPA receptor redistribution mimicked by selective dopamine neuron stimulation | Q28476676 |
| | Regulation of NMDA receptor trafficking by amyloid-beta | Q28506085 |
| | Modulation of D2R-NR2B interactions in response to cocaine | Q28566108 |
| | A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia | Q28569068 |
| | Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking | Q28570291 |
| | Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor | Q28577705 |
| | D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons | Q29619181 |
| | Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 |
| | Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors | Q30495714 |
| | Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens | Q30500199 |
| | Maturation of silent synapses in amygdala-accumbens projection contributes to incubation of cocaine craving | Q30556607 |
| | Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving. | Q30575221 |
| | Role of the ERK pathway in psychostimulant-induced locomotor sensitization. | Q33235276 |
| | Differential loss of striatal projection neurons in Huntington disease | Q33637273 |
| | Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation | Q33922831 |
| | Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons | Q33949219 |
| | Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens | Q34032832 |
| | Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice | Q34098463 |
| | Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 |
| | Physiology and pharmacology of striatal neurons | Q34607026 |
| | D1R/GluN1 complexes in the striatum integrate dopamine and glutamate signalling to control synaptic plasticity and cocaine-induced responses | Q34628184 |
| | Cocaine-evoked synaptic plasticity: a key to addiction? | Q46522113 |
| | NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum | Q46550073 |
| | Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol | Q46570512 |
| | Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum | Q46717751 |
| | Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens | Q46755939 |
| | Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors | Q46841675 |
| | Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. | Q46896175 |
| | Contrasting forms of cocaine-evoked plasticity control components of relapse | Q47868145 |
| | Expression of cocaine-evoked synaptic plasticity by GluN3A-containing NMDA receptors. | Q47954515 |
| | Rapid synthesis and synaptic insertion of GluR2 for mGluR-LTD in the ventral tegmental area | Q48093999 |
| | Reversal of cocaine-evoked synaptic potentiation resets drug-induced adaptive behaviour | Q48204993 |
| | Cyclic adenosine monophosphate-independent tyrosine phosphorylation of NR2B mediates cocaine-induced extracellular signal-regulated kinase activation. | Q48313759 |
| | A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. | Q48329693 |
| | Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons | Q48487431 |
| | Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens | Q48522950 |
| | Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression. | Q48596022 |
| | Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. | Q51423988 |
| | Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels. | Q52079554 |
| | Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo | Q58112094 |
| | Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission | Q34698478 |
| | Differential electrophysiological changes in striatal output neurons in Huntington's disease. | Q34764514 |
| | Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses | Q34990075 |
| | Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease | Q35055022 |
| | Dopaminergic modulation of synaptic transmission in cortex and striatum | Q35282100 |
| | DARPP-32: an integrator of neurotransmission | Q35639141 |
| | Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice | Q35804816 |
| | Dopaminergic signaling and striatal neurodegeneration in Huntington's disease | Q35839434 |
| | Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease | Q36016647 |
| | The Yin and Yang of dopamine release: a new perspective | Q36144612 |
| | Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 |
| | ERK2: a logical AND gate critical for drug-induced plasticity? | Q36644968 |
| | N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease | Q36692396 |
| | Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). | Q36927168 |
| | Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving | Q36953517 |
| | Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area | Q36981194 |
| | Differences in excitatory transmission between thalamic and cortical afferents to single spiny efferent neurons of rat dorsal striatum | Q37000735 |
| | Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons | Q37154244 |
| | Single-molecule imaging of the functional crosstalk between surface NMDA and dopamine D1 receptors. | Q37276714 |
| | Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease | Q37311202 |
| | Striatal plasticity and basal ganglia circuit function | Q37336143 |
| | Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. | Q37600135 |
| | Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington's disease | Q37691539 |
| | Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease | Q37954860 |
| | Modulation of NMDA receptor at the synapse: promising therapeutic interventions in disorders of the nervous system. | Q38122983 |
| | Extracellular signal-regulated protein kinases 1 and 2 activation by addictive drugs: a signal toward pathological adaptation | Q38213139 |
| | Dopaminergic modulation of striatal networks in health and Parkinson's disease | Q38233462 |
| | Direct and indirect pathways of basal ganglia: a critical reappraisal | Q38234309 |
| | Huntington's disease. Pathogenesis and management | Q39460676 |
| | Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. | Q39933436 |
| | Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. | Q40662659 |
| | Neurochemical alterations in Huntington's chorea: a study of post-mortem brain tissue | Q41530863 |
| | Bidirectional modulation of incubation of cocaine craving by silent synapse-based remodeling of prefrontal cortex to accumbens projections | Q41908316 |
| | N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons. | Q41927894 |
| | Convergence of cortical and thalamic input to direct and indirect pathway medium spiny neurons in the striatum | Q42441040 |
| | Chemical organization of projection neurons in the rat accumbens nucleus and olfactory tubercle | Q42445550 |
| | Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. | Q42455499 |
| | Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. | Q42482481 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation | Q42688388 |
| | Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum | Q42734818 |
| | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. | Q42852538 |
| | Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. | Q43187066 |
| | Functional differences between D(1) and D(5) revealed by high resolution imaging on live neurons | Q43282372 |
| | Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro | Q43517989 |
| | Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane. | Q43683702 |
| | Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers | Q43700723 |
| | Striatal neurochemical changes in transgenic models of Huntington's disease | Q44059847 |
| | Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. | Q44306949 |
| | Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 |
| | Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission | Q44536213 |
| | Spontaneous voltage oscillations in striatal projection neurons in a rat corticostriatal slice | Q44578372 |
| | Repeated exposure to amphetamine disrupts dopaminergic modulation of excitatory synaptic plasticity and neurotransmission in nucleus accumbens. | Q44632627 |
| | Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease | Q44806645 |
| | Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. | Q44931344 |
| | Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease | Q45291252 |
| | Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's disease | Q45292268 |
| | In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. | Q45293042 |
| | Heterogeneous dopamine receptor changes in early and late Huntington's disease | Q45293500 |
| | Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia | Q45299102 |
| | Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease | Q45305026 |
| | Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo | Q45306581 |
| | Striatal D1 and D2 receptor binding in patients with Huntington's disease and other choreas A PET study | Q45307413 |
| | Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc. | Q45929962 |
| | Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices | Q46133563 |
| | Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. | Q46279749 |
| | Glutamate receptors on dopamine neurons control the persistence of cocaine seeking. | Q46431401 |
| | Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior | Q46503093 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| | Huntington's disease | Q190564 |
| | Parkinson's disease | Q11085 |
| P304 | page(s) | 25 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Frontiers in Cellular Neuroscience | Q2131509 |
| P1476 | title | Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases | |
| P478 | volume | 9 | |